@jarodjmnz At the moment I bought, it was the best deal. Also really love the fact that nobody talks about it. The management is more focus than other companies on shareholders value creation
@_kelvindecosta Yeah, long run very positive. It’s just short term uncertainty with tariffs, China and demands (it should create a great opportunity). The thing is investors pay a premium for this company, so they would not accept 6% growth in 2025
I hope you didn’t invest in $HIMS over $50 because of this GLP-1 authorization… “cheaper wegovy”…
So many YouTubers recommended this stock just based on this.. if you want to invest correctly for the long run, you need to be able to do serious research 🔬
$NVO Novo Nordisk is investing $1.1B to expand its production facility in Brazil. The upgrade will boost capacity for injectable treatments for obesity, diabetes, and chronic diseases, making it one of the largest pharma investments in Brazil's history.
https://t.co/9Zo2JWoCfN
@TacticzH $HO Thales, is very expensive for a company that doesn’t have that good numbers… + MAJOR REDFLAG : French government own 26% of the company and 36% voting rights…